Home > Healthcare > Medical Services > Cell Therapy Clinical Trial Services Market

Cell Therapy Clinical Trial Services Market Share

Report ID: GMI9333
Published Date: May 2024
Report Format: PDF

Download Free Sample

Cell Therapy Clinical Trial Services Market Share

The competitive landscape of the cell therapy clinical trial services industry is characterized by the presence of established pharmaceutical & biotechnology companies along with CROs that collaborates to provide cell therapy clinical trial services vying for market share. Key players are engaging in strategic initiatives such as collaboration, investment, and partnerships to strengthen their service portfolio. The companies are actively adopting a multi-pronged approaches to address the rising demand for cell therapy clinical trial services.

Cell Therapy Clinical Trial Services Market Companies

Prominent players operating in the market are as mentioned below:

ICON PLC
IQVIA
Medpace, Inc.
LabCorp
Parexel International
Worldwide Clinical Trials
Charles River Laboratories International, Inc.
Syneos Health
Thermo Fisher Scientific Inc.
Novotech
Catalent Pharma
Precision Medicine Group, LLC

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The cell therapy clinical trial services market was valued at USD 2.6 billion in 2023 and will grow at 10.6% CAGR during 2024-2032, driven by the growing prevalence of chronic diseases, such as cancer, and cardiovascular diseases.

The regulatory affairs & compliance segment in the cell therapy clinical trial services industry generated USD 662.4 million in 2023, owing to regulatory affairs professionals that help in identifying and mitigating various risks, such as related to product variability.

North America cell therapy clinical trial services market secured a share of 43.2% in 2023, attributed to the presence of robust biopharmaceutical industry with numerous pharmaceutical and biotechnology companies.

ICON PLC, IQVIA, Medpace, Inc., LabCorp, Parexel International, Worldwide Clinical Trials, Charles River Laboratories International, Inc., Syneos Health, Thermo Fisher Scientific Inc., Novotech, Catalent Pharma and Precision Medicine Group, LLC